NAYA Biosciences Implements Reverse Stock Split Amid Struggles NAYA Biosciences has initiated a 1-for-12 reverse stock split, effective March 18, 2025, to address its stock price falling below Nasdaq's $1.00 minimum requirement. This move reduces the company's outstanding shares to approximately 666,057. However, with a 60% stock decline year-to-date, challenges persist in regaining financial stability.12